IL-4RA oligonucleotide antisense therapy (Exicure)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIL-4RA oligonucleotide antisense therapy (Exicure)
Drug Alias NameIL-4RA sperical nucleic acids (Exicure)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionInterleukin-4 receptors inhibitors
TargetsInterleukin-4 receptors
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExicure Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExicure Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A